4//SEC Filing
Kelley Kenneth J 4
Accession 0001179110-20-003999
CIK 0001159036other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:28 PM ET
Size
8.6 KB
Accession
0001179110-20-003999
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Purchase
Common Stock
2020-03-19$14.19/sh+17,543$248,933→ 242,467 total
Footnotes (3)
- [F1]Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $14.11 to $14.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F2]Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $14.23 to $14.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F3]Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $14.15 to $14.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001291219
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:28 PM ET
- Size
- 8.6 KB